Cassia Cearley files SEC Form 4 disclosures for Icosavax, Inc.. They have made 2 open-market trades across 1 company since 2022, most recently 2024-02-19.
CIK 0001874017
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ICVX | 130,694 | $2.0M |
Shares reported on the most recent Form 4, priced at the 2023-12-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICVX | SELL | 2023-12-20 | 2023-12-22 | $15.46 | $245K | +0.5% | -1.5% | N/A |
| ICVX | SELL · 10b5-1 | 2023-12-13 | 2023-12-15 | $16.01 | $280K | -0.1% | -0.6% | N/A |
| ICVX | SELL · 10b5-1 | 2023-07-31 | 2023-08-01 | $8.86 | $17K | -8.8% | -9.2% | -27.3% |
| ICVX | SELL · 10b5-1 | 2023-05-23 | 2023-05-25 | $10.00 | $100K | +7.1% | +5.7% | -15.1% |
| ICVX | SELL · 10b5-1 | 2023-03-06 | 2023-03-08 | $7.75 | $39K | -16.3% | -17.2% | +32.0% |
| ICVX | SELL · 10b5-1 | 2023-02-13 | 2023-02-15 | $10.69 | $18K | -11.0% | -30.3% | -10.3% |
| ICVX | SELL · 10b5-1 | 2022-07-29 | 2022-08-02 | $6.75 | $12K | +28.3% | -34.4% | -51.0% |
| ICVX | SELL | 2022-03-07 | 2022-03-09 | $17.15 | $335K | -8.6% | -44.4% | -58.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.